KBL Healthcare Ventures

Overview

KBL Healthcare Ventures is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies. The firm focuses on identifying companies with seasoned management teams that have the potential to create long-term value. Major areas of investment include life sciences, medical devices, healthcare services, and medical information technology. Within the life sciences sector, KBL invests in biopharmaceuticals, drug discovery platforms, and advanced materials. In the medical device area, the firm seeks companies addressing large, unmet medical needs with demonstrated clinical benefit. The firm's team comprises experienced clinicians, operators, investment bankers, and venture capital investors in the healthcare industry. Managing Directors Dr. Marlene R. Krauss and Dr. Zachary C. Berk have a combined 30 years of medical training and practice in general medicine, surgery, ophthalmology, and optometry, providing them with an extensive clinical and scientific understanding of medical technologies and markets. KBL has also assembled an Advisory Board of healthcare luminaries to assist in its efforts. KBL Healthcare Ventures has longstanding relationships with the physician, academic, and hospital communities, including institutions such as Mass General, Johns Hopkins, Columbia-Presbyterian, Brigham and Women’s, Stanford, Cleveland Clinic, New York Hospital, and Mayo Clinic. The firm leverages these networks to remain current on the latest innovations and key market trends through active management of portfolio companies and board affiliations.

Investment Focus

• Seasoned management teams
• Potential for long-term value creation
• Addressing large, unmet medical needs with demonstrated clinical benefit